Zymeworks to receive US$10 million milestone payment from BeiGene Multiple sites active and recruiting globally in North America, Europe, and Asia December 1, 2020 – VANCOUVER, British Columbia–(BUSINESS WIRE)– Zymeworks… Read More
VANCOUVER, British Columbia–(BUSINESS WIRE)– Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation… Read More
London, December 3, 2020 – LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, and Gyrus Capital (Gyrus), an investment firm dedicated to investments in the healthcare and sustainability… Read More
SAN DIEGO, Dec. 3, 2020 /PRNewswire/ — Kintara Therapeutics, Inc. (Nasdaq: KTRA) (“Kintara” or the “Company”), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced it… Read More
– Initial application with INM-088 to treat ocular disease – Vancouver, BC – December 3, 2020 – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (NASDAQ:INM; TSX:IN), a clinical-stage pharmaceutical company… Read More
